Catalyst Wire Dossier Catalyst Wire Dossier

ManNAc

N-acetylmannosamine · Leadiant Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ManNAc, covering 2017-10-19 to 2025-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Multi-Center Study of ManNAc for GNE Myopathy [Phase 2]

See pricing